KFAS
CNMD icon

Keating Financial Advisory Services’s CONMED CNMD Stock Holding History

Keating Financial Advisory Services’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$41 – 2588
2025
Q4 		$41 Buy
+1
New +$44 ﹤0.01% 2166

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Keating Financial Advisory Services's CNMD Position: Q1 2026 in Review

Keating Financial Advisory Services sold out of CONMED (CNMD) in Q1 2026, closing a stake of 1 share — an estimated $41 sold.

Keating Financial Advisory Services first reported a position in CNMD in Q4 2025 and held it in 1 quarter. The position peaked at $41 in Q4 2025. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Keating Financial Advisory Services reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
  • Keating Financial Advisory Services sold 1 CONMED share in Q1 2026, an estimated $41.
  • Keating Financial Advisory Services first reported a position in CONMED in Q4 2025 and held it in 1 quarter.
  • Keating Financial Advisory Services's CONMED position peaked at $41 in Q4 2025.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Keating Financial Advisory Services's 13F filing for Q1 2026, filed 15 May 2026.